Ctd Holdings Inc  (CTDH)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
Price: $0.2000 $0.02 9.890%
Day's High: $0.2 Week Perf: 11.11 %
Day's Low: $ 0.18 30 Day Perf: 5.26 %
Volume (M): 62 52 Wk High: $ 1.18
Volume (M$): $ 12 52 Wk Avg: $0.53
Open: $0.18 52 Wk Low: $0.16

 Market Capitalization (Millions $) 20
 Shares Outstanding (Millions) 101
 Employees 6
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) 5
 Capital Exp. (TTM) (Millions $) 0

Ctd Holdings Inc

We are a biotechnology company that develops cyclodextrin-based products for the treatment of disease. We filed a Type II Drug Master File with the U.S. Food and Drug Administration (“FDA”) in 2014 for our lead drug candidate, Trappsol® Cyclo™ (hydroxypropyl beta cyclodextrin) as a treatment for Neimann-Pick Type C disease (“NPC”). NPC is a rare and fatal cholesterol metabolism disease found primarily in children and young adults. In 2015, we launched an International Clinical Program for Trappsol® Cyclo™ as a treatment for NPC. In 2016, we filed an Investigational New Drug application (“IND”) with the FDA, which describes our Phase I clinical plans for a randomized, double blind, parallel group study at a single clinical site in the US. The IND was approved by the FDA in September 2016, and in January 2017 the FDA granted Fast Track designation to Trappsol® Cyclo™ for the treatment of NPC. We have also filed Clinical Trial Applications with several European regulators, including the United Kingdom's Medicines and Healthcare Products Regulatory Agency, which approved our application. We expect to commence a U.S. clinical study in 2017 in which we will provide Trappsol® Cyclo™ intravenously to NPC patients two years of age and older in order to track biochemical markers of cholesterol metabolism and to measure effects on neurologic, lung and liver symptoms, with similar studies to be conducted in Europe.

   CTDH is expected to report next financial results on November 11, 2019.

Ctd Holdings Inc's Segments
  Company Estimates  
  Revenue Outlook
Ctd Holdings Inc does not provide revenue guidance.

Earnings Outlook
Ctd Holdings Inc does not provide earnings estimates.

Geographic Revenue Dispersion

Guess Inc

EPS and Sales Advanced

Guess Inc reported solid second quarter, where Sales grew by 5.78 % to $683.22 millions in comparison to $645.87 millions on a year-over-year basis, company posted earnings growth of 12.9 % to $0.35, as comparison at $0.31 in the prior year quarter.

Strattec Security Corp

Company Fail to Break-even Despite Surge in Sales

Company slipped into loss at $-0.02 per share in the forth quarter, although it's Sales surged by 45.22 % to $149.84 millions from the same quarter a year ago.

Matrix Service Co

Income Positive Again, Sharp Topline Growth

Matrix Service Co announced earnings per share of $0.47 and Sales of $358.89 millions in the forth quarter, Company's earnings turn positive per share, versus $-0.55 eps, earned in the same quarter a year ago, although Matrix Service Co saw it's Sales rise by 36.04 % in the same period.

Top Ships Inc.

Losses Widen but Revenues Unchanged

In the second quarter Top Ships Inc increased losses of $-11.59 per share compare to $0.00 a year ago and increased losses from $-0.61 per share from the previous quarter.

Sales remained unchanged to $29.79 millions from $0.00 millions in the same quarter a year ago and sequentially Sales fell by -27.44 % from $41.05 millions.

Rex American Resources Corp

A $2.62 million tax benefit, helped Rex American Resources Corp to post $0.36 eps in the second quarter

A $2.62 million tax benefit, helped Rex American Resources Corp to post $0.36 eps in the second quarter

Major Competitors Stock performance

5 Days Decrease / Increase
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

LNGB's Profile

Stock Price

LNGB's Financials

Business Description


Charts & Quotes

LNGB's News


LNGB's Competitors

Customers & Markets

Economic Indicators

LNGB's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071